[1] |
Savage KJ, Al-Rajhi N, Voss N, et al. Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience[J]. Ann Oncol??2006,17(1):123-30.
|
[2] |
Avilés A, Neri N, Fernández R, et al. Randomized clinical trial to assess the efficacy of radiotherapy in primary mediastinal large B-lymphoma[J]. Int J Radiat Oncol Biol Phys, 2012,83(4):1227-31.
|
[3] |
Xu LM, Fang H, Wang WH,et al. Prognostic significance of rituximab and radiotherapy for patients with primary mediastinal large B-cell lymphoma receiving doxorubicin-containing chemotherapy[J]. Leuk Lymphoma, 2012,54(8):1684-90.
|
[4] |
Vassilakopoulos TP, Pangalis GA, Katsigiannis A, et al. Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of care[J].Oncologist,2012,17(2):239-49.
|
[5] |
Tai WM, Quah D, Yap SP, et al. Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factors in 41 consecutive Asian patients[J]. Leuk Lymphoma,2011,52(4):604-12.
|
[6] |
Dunleavy K, Pittaluga S, Maeda LS,et al. Dose-adjusted EPOCHrituximab therapy in primary mediastinal B-cell lymphoma[J].N Engl J Med,2013,368(15):1408-16.
|
[7] |
Liu L, Liu Q, Cheng RA, et al. Clinical analysis of autologous peripheral blood stem cell transplantation combined with local radiotherapy for treatment of 16 case with massive type of mediastinal lymphoma[J]. Nei Ke Ji Wei Zhong Zheng Za Zhi, 20 08,14(6):316-7.[刘利, 刘强, 陈任安,等.自体外周血干细胞移 植联合受累野放疗治疗纵隔巨块型淋巴瘤16例临床分析[J].内 科急危重症杂志,2008,14(6):316-7.]
|